Doshi, S. D., Oza, J., Remotti, H., Remotti, F., Moy, M. P., Schwartz, G. K., & Ingham, M. (2021). Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated Sarcoma. JCO Precision Oncology, 5, 1–5. https://doi.org/10.1200/po.20.00201